Home » Newsletters » BioWorld Science

BioWorld Science

June 27, 2022

View Archived Issues

Ginisortamab restores gremlin-1-ablated BMP signaling in CRC cell lines

Novel murine model may shed light for future strategies for aggressive glioblastoma

Servier patents new MAT2A inhibitors

Sumitomo Pharma divulges Chk1 inhibitors

Anti-HER2 domain-specific antibody-drug radioconjugates show promise in models of breast cancer

SAGE Therapeutics describes new GABA-A receptor modulators

Merck & Co. identifies new GLCT-1 inhibitors

Tokyo University of Science discloses LXR antagonists

Silo in commercial evaluation license agreement for next-generation liposomes for autoimmune disease

Dual CXCR4/ACKR3 inhibitor in combination with ICT impedes 4T1 tumor growth and metastasis

FDA clears Fusion's IND applications for FPI-2059 and imaging analogue FPI-2058

[89Zr]-Labeled antibody targeting glypican-1 developed as theranostic for pancreatic cancer

First preclinical data on NR2F6 antagonist TES-4207

Molecular signature predicts cancer risk in patients with NAFLD

Voltron initiates preclinical study of vaccine candidate VTX-067 in immune-oncology model

SAN-903 dampens renal fibrosis in mouse model of chronic kidney disease

Evaxion to advance EVX-03 into clinic for NSCLC

Brilacidin inhibits Omicron, Delta, Gamma and Alpha SARS-CoV-2 variants in vitro

Soligenix reports 100% protection in NHPs with bivalent vaccine against MARV and SUDV

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 27, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Muted and missing M&As: JPM deals absent in 2026
BioWorld
For years, the J.P. Morgan Healthcare Conference (JPM) kicked off with splashy headlines of major M&A activity among biopharma companies, but in 2026, the hype...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...